Ken Research Logo

Qatar assisted reproductive technology market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Qatar Assisted Reproductive Technology market is worth USD 120 million, fueled by increasing demand for IVF, ICSI, and other services amid rising infertility and awareness.

Region:Middle East

Author(s):Geetanshi

Product Code:KRAC8220

Pages:84

Published On:November 2025

About the Report

Base Year 2024

Qatar Assisted Reproductive Technology Market Overview

  • The Qatar Assisted Reproductive Technology market is valued at USD 120 million, based on a five-year historical analysis. This growth is primarily driven by increasing infertility rates, rising awareness about reproductive health, and advancements in medical technology. The demand for assisted reproductive services has surged as more couples seek effective solutions to conceive, leading to a robust market environment .
  • Key players in this market include Doha, Al Rayyan, and Umm Salal, which dominate due to their advanced healthcare infrastructure and the availability of specialized fertility clinics. These cities have established themselves as hubs for reproductive health services, attracting both local and international patients seeking high-quality assisted reproductive technologies .
  • The Assisted Reproductive Technology Clinics Licensing and Regulation Policy, issued by the Ministry of Public Health, Qatar in 2023, mandates that all fertility clinics obtain official accreditation and comply with international standards for patient safety, laboratory practices, and reporting. This regulation requires clinics to meet specific operational, staffing, and equipment criteria, and mandates regular audits to ensure ongoing compliance, thereby enhancing the quality and reliability of assisted reproductive services in the country .
Qatar Assisted Reproductive Technology Market Size

Qatar Assisted Reproductive Technology Market Segmentation

By Type:The market is segmented into various types of assisted reproductive technologies, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, Sperm Freezing, Preimplantation Genetic Testing (PGT), Intrauterine Insemination (IUI), Gamete Intrafallopian Transfer (GIFT), and others. Among these, IVF is the most widely adopted method due to its high success rates and increasing acceptance among couples facing infertility challenges. The growing trend of egg and sperm freezing is also gaining traction as individuals seek to delay parenthood for personal or professional reasons .

Qatar Assisted Reproductive Technology Market segmentation by Type.

By End-User:The assisted reproductive technology market is utilized by various end-users, including fertility clinics, hospitals, research institutions, home care settings, and others. Fertility clinics are the leading end-users due to their specialized services and focus on reproductive health. Hospitals also play a significant role, particularly in providing comprehensive healthcare services that include assisted reproductive technologies. The increasing number of fertility clinics in urban areas is contributing to the growth of this segment .

Qatar Assisted Reproductive Technology Market segmentation by End-User.

Qatar Assisted Reproductive Technology Market Competitive Landscape

The Qatar Assisted Reproductive Technology Market is characterized by a dynamic mix of regional and international players. Leading participants such as Sidra Medicine, Qatar Fertility Center, Doha Clinic Hospital, Al-Ahli Hospital, Hamad Medical Corporation – Women's Wellness and Research Center, Al Emadi Hospital, The Cuban Hospital, Al Wakra Hospital, American Hospital Clinics, New Hope IVF Gynaecology & Fertility Hospital, The IVF Clinic, Royal Medical Center, Al Hayat Medical Center, The Women's Hospital (HMC), Qatar University Fertility Research Center contribute to innovation, geographic expansion, and service delivery in this space.

Sidra Medicine

2018

Doha, Qatar

Qatar Fertility Center

2013

Doha, Qatar

Doha Clinic Hospital

2001

Doha, Qatar

Al-Ahli Hospital

2004

Doha, Qatar

Hamad Medical Corporation – Women's Wellness and Research Center

2017

Doha, Qatar

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Number of ART Procedures Performed Annually

Clinical Pregnancy Rate per Cycle

Live Birth Rate per Cycle

Patient Satisfaction Score

Market Penetration Rate (Share of ART cycles in Qatar)

Qatar Assisted Reproductive Technology Market Industry Analysis

Growth Drivers

  • Increasing Infertility Rates:The prevalence of infertility in Qatar has risen significantly, with approximately 16% of couples facing challenges in conceiving. This increase is attributed to various factors, including lifestyle changes and delayed childbearing. According to the Qatar Ministry of Public Health, the number of couples seeking fertility treatments has surged by 25% over the past five years, indicating a growing demand for assisted reproductive technologies (ART) as a viable solution for infertility issues.
  • Advancements in Reproductive Technologies:The ART sector in Qatar is experiencing rapid technological advancements, with new techniques such as preimplantation genetic testing (PGT) and cryopreservation gaining traction. In future, it is estimated that over 35% of fertility clinics in Qatar will adopt these advanced technologies, enhancing success rates and patient outcomes. The integration of cutting-edge technologies is expected to attract more patients, further driving market growth and improving overall service quality in the region.
  • Government Support and Funding Initiatives:The Qatari government has recognized the importance of addressing infertility and has implemented various funding initiatives to support ART. In future, the government allocated approximately QAR 60 million to subsidize fertility treatments for eligible couples. This financial support not only reduces the burden of high treatment costs but also encourages more couples to seek ART services, thereby expanding the market and improving access to necessary treatments.

Market Challenges

  • High Treatment Costs:One of the significant barriers to accessing ART in Qatar is the high cost associated with treatments, which can range from QAR 18,000 to QAR 32,000 per cycle. Many couples find these expenses prohibitive, especially in a country where healthcare costs are rising. As a result, a substantial portion of the population remains unable to afford necessary treatments, limiting the overall market potential and accessibility of ART services.
  • Cultural and Social Stigmas:Cultural perceptions surrounding infertility and ART can pose challenges in Qatar. Many couples face societal pressure and stigma, which may deter them from seeking treatment. A survey conducted by the Qatar University indicated that nearly 45% of respondents felt uncomfortable discussing infertility issues publicly. This stigma can lead to delayed treatment and reduced demand for ART services, ultimately impacting market growth and patient engagement.

Qatar Assisted Reproductive Technology Market Future Outlook

The future of the ART market in Qatar appears promising, driven by increasing awareness and acceptance of fertility treatments. As more couples seek assistance, the demand for innovative technologies and personalized care will likely rise. Additionally, the integration of telemedicine and AI in ART procedures is expected to enhance patient experiences and outcomes. With ongoing government support and a focus on ethical practices, the market is poised for significant growth, addressing both the needs of patients and the challenges faced by providers.

Market Opportunities

  • Expansion of Fertility Clinics:There is a significant opportunity for the establishment of new fertility clinics in Qatar, particularly in underserved areas. With a growing population and increasing infertility rates, the demand for accessible ART services is expected to rise. This expansion can lead to improved patient access and increased competition, ultimately benefiting couples seeking fertility treatments.
  • Collaborations with International Fertility Experts:Partnering with international fertility specialists can enhance the quality of ART services in Qatar. Such collaborations can facilitate knowledge transfer, introduce advanced techniques, and improve treatment success rates. By leveraging global expertise, local clinics can attract more patients and establish Qatar as a regional hub for reproductive health services.

Scope of the Report

SegmentSub-Segments
By Type

In Vitro Fertilization (IVF)

Intracytoplasmic Sperm Injection (ICSI)

Egg Freezing

Sperm Freezing

Preimplantation Genetic Testing (PGT)

Intrauterine Insemination (IUI)

Gamete Intrafallopian Transfer (GIFT)

Others

By End-User

Fertility Clinics

Hospitals

Research Institutions

Home Care Settings

Others

By Age Group

Under 30

35

40

Over 40

Others

By Treatment Type

Fresh Embryo Transfer

Frozen Embryo Transfer

Donor Egg IVF

Donor Sperm IVF

Others

By Geographic Distribution

Doha

Al Rayyan

Umm Salal

Al Wakra

Others

By Success Rate

High Success Rate Clinics

Moderate Success Rate Clinics

Low Success Rate Clinics

Others

By Insurance Coverage

Fully Covered

Partially Covered

Not Covered

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Qatar Ministry of Public Health)

Healthcare Providers and Fertility Clinics

Pharmaceutical Companies specializing in reproductive health

Medical Device Manufacturers

Health Insurance Companies

Biotechnology Firms

Non-Governmental Organizations (NGOs) focused on reproductive health

Players Mentioned in the Report:

Sidra Medicine

Qatar Fertility Center

Doha Clinic Hospital

Al-Ahli Hospital

Hamad Medical Corporation Women's Wellness and Research Center

Al Emadi Hospital

The Cuban Hospital

Al Wakra Hospital

American Hospital Clinics

New Hope IVF Gynaecology & Fertility Hospital

The IVF Clinic

Royal Medical Center

Al Hayat Medical Center

The Women's Hospital (HMC)

Qatar University Fertility Research Center

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Qatar Assisted Reproductive Technology Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Qatar Assisted Reproductive Technology Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Qatar Assisted Reproductive Technology Market Analysis

3.1 Growth Drivers

3.1.1 Increasing infertility rates
3.1.2 Advancements in reproductive technologies
3.1.3 Rising awareness and acceptance of ART
3.1.4 Government support and funding initiatives

3.2 Market Challenges

3.2.1 High treatment costs
3.2.2 Limited access to specialized clinics
3.2.3 Cultural and social stigmas
3.2.4 Regulatory hurdles

3.3 Market Opportunities

3.3.1 Expansion of fertility clinics
3.3.2 Development of new ART technologies
3.3.3 Collaborations with international fertility experts
3.3.4 Increasing demand for egg and sperm donation

3.4 Market Trends

3.4.1 Rise in telemedicine for fertility consultations
3.4.2 Personalized treatment plans
3.4.3 Integration of AI in ART procedures
3.4.4 Focus on holistic patient care

3.5 Government Regulation

3.5.1 Licensing requirements for fertility clinics
3.5.2 Regulations on embryo storage
3.5.3 Guidelines for donor anonymity
3.5.4 Ethical considerations in ART practices

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Qatar Assisted Reproductive Technology Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Qatar Assisted Reproductive Technology Market Segmentation

8.1 By Type

8.1.1 In Vitro Fertilization (IVF)
8.1.2 Intracytoplasmic Sperm Injection (ICSI)
8.1.3 Egg Freezing
8.1.4 Sperm Freezing
8.1.5 Preimplantation Genetic Testing (PGT)
8.1.6 Intrauterine Insemination (IUI)
8.1.7 Gamete Intrafallopian Transfer (GIFT)
8.1.8 Others

8.2 By End-User

8.2.1 Fertility Clinics
8.2.2 Hospitals
8.2.3 Research Institutions
8.2.4 Home Care Settings
8.2.5 Others

8.3 By Age Group

8.3.1 Under 30
8.3.2 30-35
8.3.3 36-40
8.3.4 Over 40
8.3.5 Others

8.4 By Treatment Type

8.4.1 Fresh Embryo Transfer
8.4.2 Frozen Embryo Transfer
8.4.3 Donor Egg IVF
8.4.4 Donor Sperm IVF
8.4.5 Others

8.5 By Geographic Distribution

8.5.1 Doha
8.5.2 Al Rayyan
8.5.3 Umm Salal
8.5.4 Al Wakra
8.5.5 Others

8.6 By Success Rate

8.6.1 High Success Rate Clinics
8.6.2 Moderate Success Rate Clinics
8.6.3 Low Success Rate Clinics
8.6.4 Others

8.7 By Insurance Coverage

8.7.1 Fully Covered
8.7.2 Partially Covered
8.7.3 Not Covered
8.7.4 Others

9. Qatar Assisted Reproductive Technology Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Number of ART Procedures Performed Annually
9.2.4 Clinical Pregnancy Rate per Cycle
9.2.5 Live Birth Rate per Cycle
9.2.6 Patient Satisfaction Score
9.2.7 Market Penetration Rate (Share of ART cycles in Qatar)
9.2.8 Average Treatment Cost (USD)
9.2.9 Range of Services Offered (IVF, ICSI, IUI, PGT, etc.)
9.2.10 Accreditation and Certifications (e.g., JCI, ISO)
9.2.11 Research and Development Investment
9.2.12 Brand Recognition (Local/Regional/International)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Sidra Medicine
9.5.2 Qatar Fertility Center
9.5.3 Doha Clinic Hospital
9.5.4 Al-Ahli Hospital
9.5.5 Hamad Medical Corporation – Women's Wellness and Research Center
9.5.6 Al Emadi Hospital
9.5.7 The Cuban Hospital
9.5.8 Al Wakra Hospital
9.5.9 American Hospital Clinics
9.5.10 New Hope IVF Gynaecology & Fertility Hospital
9.5.11 The IVF Clinic
9.5.12 Royal Medical Center
9.5.13 Al Hayat Medical Center
9.5.14 The Women's Hospital (HMC)
9.5.15 Qatar University Fertility Research Center

10. Qatar Assisted Reproductive Technology Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Public Health
10.1.2 Ministry of Education
10.1.3 Ministry of Social Development
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in ART Facilities
10.2.2 Funding for Research and Development
10.2.3 Partnerships with International Clinics
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Financial Constraints
10.3.2 Emotional Stress
10.3.3 Lack of Information
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Accessibility of Services
10.4.3 Cultural Acceptance
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Long-term Success Rates
10.5.2 Patient Retention Rates
10.5.3 Expansion of Services Offered
10.5.4 Others

11. Qatar Assisted Reproductive Technology Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of government health statistics and fertility rates in Qatar
  • Review of published reports from healthcare organizations and fertility clinics
  • Examination of demographic data and trends affecting reproductive health

Primary Research

  • Interviews with reproductive endocrinologists and fertility specialists in Qatar
  • Surveys with patients who have undergone assisted reproductive technology (ART) procedures
  • Focus groups with healthcare administrators from fertility clinics

Validation & Triangulation

  • Cross-validation of findings with international ART market trends
  • Triangulation of data from clinical studies and patient feedback
  • Sanity checks through expert panel reviews comprising healthcare professionals

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the ART market size based on national healthcare expenditure
  • Segmentation by types of ART services offered (IVF, ICSI, etc.)
  • Incorporation of government health initiatives promoting reproductive health

Bottom-up Modeling

  • Data collection from leading fertility clinics on service pricing and patient volumes
  • Operational cost analysis of ART procedures and associated services
  • Volume x cost calculations for each ART service type

Forecasting & Scenario Analysis

  • Multi-factor regression analysis considering socio-economic factors and healthcare access
  • Scenario modeling based on potential changes in healthcare policies and insurance coverage
  • Baseline, optimistic, and pessimistic projections for ART market growth through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
IVF Treatment Insights80Fertility Specialists, IVF Coordinators
Patient Experience with ART120Patients who have undergone ART procedures
Healthcare Policy Impact60Healthcare Administrators, Policy Makers
Market Trends in Reproductive Health50Healthcare Analysts, Market Researchers
Insurance Coverage for ART40Insurance Providers, Financial Advisors

Frequently Asked Questions

What is the current value of the Qatar Assisted Reproductive Technology market?

The Qatar Assisted Reproductive Technology market is valued at approximately USD 120 million, reflecting a significant growth driven by increasing infertility rates, heightened awareness of reproductive health, and advancements in medical technology.

What factors are driving the growth of the Assisted Reproductive Technology market in Qatar?

Which cities in Qatar are prominent for Assisted Reproductive Technology services?

What types of Assisted Reproductive Technologies are available in Qatar?

Other Regional/Country Reports

Indonesia Assisted Reproductive Technology Market

Malaysia Assisted Reproductive Technology Market

KSA Assisted Reproductive Technology Market

APAC Assisted Reproductive Technology Market

SEA Assisted Reproductive Technology Market

Vietnam Assisted Reproductive Technology Market

Other Adjacent Reports

Philippines In Vitro Fertilization Market

UAE Fertility Clinics Market

Malaysia Genetic Testing Market

Egypt Cryopreservation Services Market

South Korea Reproductive Health Pharmaceuticals Market

Singapore Medical Tourism Market

Singapore Women\s Health Services Market

South Korea Preimplantation Genetic Diagnosis Market

Bahrain Telemedicine in Fertility Market

Vietnam Healthcare Infrastructure Development Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022